CD44, an integral membrane glycoprotein expressed by many cell types, serve
s as the principal transmembrane hyaluronate receptor and might be a determ
inant of metastatic and invasive behaviour in carcinomas. The generation of
CD44 splice variants might be linked closely with gastric carcinoma tumori
genesis and differentiation. Some studies have reported that the magnitude
of CD44 variant synthesis at the protein level correlates with lymph node m
etastasis. A number of studies have examined the possible mechanism of invo
lvement of the CD44 variant in tumour metastasis. Most studies have reporte
d that the regulation of CD44 binding to hyaluronate results from glycosyla
tion of variably spliced exons. Direct hyaluronate binding studies of CD44
V4-V7 isoforms transfected into the human gastric carcinoma cell line, SC-M
1, have indicated that the V4-V7 isoforms themselves, in addition to glycos
ylation, can alter hyaluronate binding.